The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

FLGT FINANCIAL STATEMENTS

Fulgent Genetics Inc — balance sheet, income statement and cash flow trends

FLGTFulgent Genetics Inc

🇺🇸 USA · NASDAQ · Healthcare · Diagnostics & Research

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
0500 M1 B202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue323.9 M $Gross Profit115.3 M $ · 36%Operating Income-120.1 M $ · -37%Pre-tax Income-91.1 M $ · -28%Net Income to Owners-84.4 M $ · -26%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue323.9 M $+6.8%
Gross Profit115.3 M $-5.1%
Operating Income-120.1 M $—
EBITDA-65 M $—
Net Income to Owners-84.4 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0500 M1 B1.5 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets1.1 B
  • Equity1 B $91%
  • Current Liabilities71.8 M $7%
  • Long-term Liabilities21.5 M $2%

Key Figures

YoY change
Total Assets1.1 B $-9.2%
Total Liabilities93.2 M $+5.7%
Total Equity1 B $-10.3%
Cash & ST Investments257 M $-12.3%
Total Debt9.4 M $+27.6%
Net Debt-16.9 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
0200 M400 M600 M202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-50 M0-83.7 M $Operating92 M $Investing-70 M $Financing-61.8 M $Net Change

Key Figures

YoY change
Operating Cash Flow-83.7 M $—
Capital Expenditures20.1 M $-42.4%
Free Cash Flow-103.8 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on FLGT

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.